SEGMENTED INFORMATION (Details) - USD ($)	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Revenue	$ 3,449,159	$ 3,070,026
COST OF REVENUE	(2,866,594)	(2,414,719)
Gross profit	582,565	655,307
Other income	62,388	746,641
General and administrative	(302,851)	(328,418)
FINANCE COSTS	(3,358)	(3,026)
Profit/(Loss) before tax	338,744	1,070,504
Tax expense	0	(860)
Net profit	338,744	1,069,644
Chemrex Corporation Sdn. Bhd. [Member]
Revenue	3,351,796	3,070,026
COST OF REVENUE	(2,798,887)	(2,401,727)
Gross profit	552,909	668,299
Other income	61,625	741,896
General and administrative	(233,152)	(290,635)
FINANCE COSTS	(2,151)	(1,963)
Profit/(Loss) before tax	379,231	1,117,597
Tax expense	0	0
Net profit	379,231	1,117,597
BioNexus [Member]
Revenue	97,363	0
COST OF REVENUE	(67,707)	(12,992)
Gross profit	29,656	(12,992)
Other income	763	4,745
General and administrative	(22,511)	(20,149)
FINANCE COSTS	(1,207)	(1,063)
Profit/(Loss) before tax	6,701	(29,459)
Tax expense	0	860
Net profit	6,701	(30,319)
TOTAL [Member]
Revenue	3,449,159	3,070,026
COST OF REVENUE	(2,866,594)	(2,414,719)
Gross profit	582,565	655,307
Other income	62,388	746,641
General and administrative	(255,663)	(310,784)
FINANCE COSTS	(3,358)	(3,026)
Profit/(Loss) before tax	385,932	1,088,138
Tax expense	0	(860)
Net profit	$ 385,932	$ 1,087,278